Pharmacokinetics of EDP-420 after multiple oral doses in healthy adult volunteers and in a bioequivalence study

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 8, 2009, Pages 3218-3225

  Jiang, Li Juan ^a   Yat, Sun Or ^a  

^a Enanta Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 ACETYLIMINO 3 DEHEXAPYRANOSYLOXY 9 DEOXO 3 OXO 6 O,11 O [2 [6 (1 PYRAZOLYL) 3 PYRIDINYLMETHOXYIMINO]PROPYLENE]ERYTHROMYCIN; MACROLIDE; PLACEBO;

ADULT; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG FORMULATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID DIET; LOADING DRUG DOSE; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BRIDGED COMPOUNDS; FEMALE; HUMANS; MACROLIDES; MALE; MIDDLE AGED; MOLECULAR STRUCTURE; THERAPEUTIC EQUIVALENCY; YOUNG ADULT;

EID: 67749127609     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00022-09     Document Type: Article

References (39)

1. Bartlett, J. G., R. F. Breiman, L. A. Mandell, T. M. File, Jr., et al. 1998. Community-acquired pneumonia in adults: guidelines for management. Clin. Infect. Dis. 26:811-838.
2. Bermudez, L., N. Motamedi, M. Wu, L. S. Young, G. Wang, and L. T. Phan. 2007. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., abstr. B-1224.
3. Bermudez, L. E., M. D. McNab, L. S. Young, G. Wang, and L. T. Phan. 2005. Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F-2035.
4. Bermudez, L. E., N. Motamedi, C. Chee, G. Baimukanova, P. Kolonoski, C. Inderlied, P. Aralar, G. Wang, L. T. Phan, and L. S. Young. 2007. EDP-420, a bicyclolide (bridged bicyclic macrolide), is active against Mycobacterium avium. Antimicrob. Agents Chemother. 51:1666-1670.
5. Blasi, F., and P. Tarsia. 2005. Value of short-course antimicrobial therapy in community-acquired pneumonia. Int. J. Antimicrob. Agents 26(Suppl. 3): S148-S155.
6. Blumer, J. L. 2005. Evolution of a new drug formulation: the rationale for high-dose, short-course therapy with azithromycin. Int. J. Antimicrob. Agents 26(Suppl. 3):S143-S147.
7. Chu, S. Y., L. T. Sennello, S. T. Bunnell, L. L. Varga, D. S. Wilson, and R. C. Sonders. 1992. Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses. Antimicrob. Agents Chemother. 36:2447-2453.
8. Coates, P., R. Daniel, A. C. Houston, J. H. Antrobus, and T. Taylor. 1991. An open study to compare the pharmacokinetics, safety and tolerability of a multiple-dose regimen of azithromycin in young and elderly volunteers. Eur. J. Clin. Microbiol. Infect. Dis. 10:850-852.
9. Conte, J. E., Jr., J. Golden, S. Duncan, E. McKenna, E. Lin, and E. Zurlinden. 1996. Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. Antimicrob. Agents Chemother. 40:1617-1622.
10. Dubois, J., and M. Paris. 2006. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother., abstr. E-1859.
11. File, T. M., Jr. 2004. Clinical efficacy of newer agents in short-duration therapy for community-acquired pneumonia. Clin. Infect. Dis. 39(Suppl. 3):S159-S164.
12. Furuie, H., S. Irie, Y. Saisho, T. Yoshikawa, and J. Shimada. 2007. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., abstr. A-798.
13. Hoban, D. J., A. K. Wierzbowski, K. Nichol, and G. G. Zhanel. 2001. Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides. Antimicrob. Agents Chemother. 45:2147-2150.
14. Jiang, L. J., D. Wachtel, T. Phan, A. Sonderfan, and Y. S. Or. 2007. Abstr. 17th Eur. Congr. Clin. Microbiol. Infect. Dis.-25th Int. Congr. Chemother., abstr. F-2091.
15. Jiang, L. J., G. L. Drusano, P. Nguyen, T. Murphy, A. Arya, L. T. Phan, A. Sonderfan, and Y. S. Or. 2005. Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother., abstr. A-26.
16. Jiang, L. J., G. Wang, L. T. Phan, A. Sonderfan, M. Paris, and Y. S. Or. 2007. Abstr. 17th Eur. Congr. Clin. Microbiol. Infect. Dis.-25th Int. Congr. Chemother., abstr. F-2092.
17. Jiang, L. J., M. Takeuchi, R. Lewsley, T. Baba, A. Sonderfan, and Y. S. Or. 2007. Abstr. 17th Eur. Congr. Clin. Microbiol. Infect. Dis.-25th Int. Congr. Chemother., abstr. F-2093.
18. Jiang, L. J., M. Wang, and Y. S. Or. 2007. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., abstr. A-800.
19. Kawai, Y., and N. Gotoh. 2006. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother., abstr. E-1855.
20. Kohno, S., K. Yamaguchi, Y. Tanigawara, A. Watanabe, N. Aoki, Y. Niki, and J. Fujita. 2007. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., abstr. L-485.
21. Lode, H. 1991. The pharmacokinetics of azithromycin and their clinical significance. Eur. J. Clin. Microbiol. Infect. Dis. 10:807-812.
22. Luo, X., R. Wu, D. Mu, L. T. Phan, G. Wang, A. Polemeropoulos, and Y. S. Or. 2007. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F-2848.
23. Maglio, D., H. K. Sun, T. Patel, M. A. Banevicius, C. H. Nightingale, G. Wang, Z. Chen, L. T. Phan, and D. P. Nicolau. 2004. Abstr. 44th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F-1408.
24. Maki, H., T. Fujimura, Y. Yamano, J. Shimada, and S. Kuwahara. 2005. Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F-2029.
25. Matsuda, H., Y. Kawai, Y. Yamano, and N. Gotoh. 2007. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F-1678.
26. Niederman, M. S. 2005. Principles of appropriate antibiotic use. Int. J. Antimicrob. Agents 26(Suppl. 3):S170-S175.
27. Phan, L. T., A. Polemeropoulos, G. Wang, and Y. S. Or. 2006. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother., abstr. E-1858.
28. Sato, T., K. Takada, Y. Ishii, S. Kimura, A. Ohno, S. Miyazaki, and K. Yamaguchi. 2006. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother., abstr. E-1856.
29. Sato, T., K. Takada, Y. Ishii, S. Kimura, A. Ohno, S. Miyazaki, and K. Yamaguchi. 2007. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., abstr. E-1629.
30. Sato, T., K. Takada, Y. Ishii, S. Kimura, A. Ohno, S. Miyazaki, and K. Yamaguchi. 2007. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., abstr. E-1630.
31. Sato, T., K. Takada, Y. Ishii, S. Kimura, A. Ohno, S. Miyazaki, and K. Yamaguchi. 2007. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., abstr. E-1628.
32. Scorneaux, B., A. Arya, A. Polemeropoulos, M. Lillard, F. Han, K. Amsler, A. Sonderfan, G. Wang, Y. Peng, G. Xu, H. Kim, T. Lien, L. T. Phan, and Y. S. Or. 2003. Abstr. 43rd Intersci. Conf. Antimicrob. Agents Chemother., abstr. F-1191.
33. Stucki, A., P. Gerber, F. Acosta, M. Cottagnoud, P. Cottagnoud, L. Jiang, P. Nguyen, D. Wachtel, G. Wang, and L. T. Phan. 2008. Effects of EDP-420 on penicillin-resistant and quinolone- and penicillin-resistant pneumococci in the rabbit meningitis model. J. Antimicrob. Chemother. 61:665-669.
34. Tsuji, M., H. Miwa, M. Takema, E. Kanaoka, T. Yoshikawa, J. Shimada, and S. Kuwahara. 2005. Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F-2035.
35. Tuominen, R. K., P. T. Mannisto, P. Pohto, A. Solkinen, and A. Vuorela. 1988. Absorption of erythromycin acistrate and erythromycin base in the fasting and non-fasting state. J. Antimicrob. Chemother. 21(Suppl. D):45-55.
36. Wang, G., D. Niu, Y. L. Qiu, L. T. Phan, Z. Chen, A. Polemeropoulos, and Y. S. Or. 2004. Synthesis of novel 6,11-O-bridged bicyclic ketolides via a palladium-catalyzed bis-allylation. Org. Lett. 6:4455-4458.
37. Wierzbowski, A. K., D. J. Hoban, T. Hisanaga, M. Decorby, and G. G. Zhanel. 2005. The use of macrolides in treatment of upper respiratory tract infections. Curr. Infect. Dis. Rep. 7:175-184.
38. Wierzbowski, A. K., K. Nichol, N. Laing, T. Hisanaga, A. Nikulin, J. A. Karlowsky, D. J. Hoban, and G. G. Zhanel. 2007. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998-2004). J. Antimicrob. Chemother. 60:733-740.
39. Yamano, Y., T. Fujumura, H. Maki, J. Shimada, and S. Kuwahara. 2006. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother., abstr. E-1857.